471 related articles for article (PubMed ID: 28543885)
1. DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection technique.
Dehkordi ANV; Kamali-Asl A; Wen N; Mikkelsen T; Chetty IJ; Bagher-Ebadian H
NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28543885
[TBL] [Abstract][Full Text] [Related]
2. Optimization of DCE-MRI protocol for the assessment of patients with brain tumors.
Artzi M; Liberman G; Nadav G; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
Magn Reson Imaging; 2016 Nov; 34(9):1242-1247. PubMed ID: 27451404
[TBL] [Abstract][Full Text] [Related]
3. Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.
Bonekamp D; Deike K; Wiestler B; Wick W; Bendszus M; Radbruch A; Heiland S
J Magn Reson Imaging; 2015 Jul; 42(1):87-96. PubMed ID: 25244574
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions.
Kang Y; Hong EK; Rhim JH; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SW; Choi SH
Korean J Radiol; 2020 Jun; 21(6):707-716. PubMed ID: 32410409
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
6. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
Kang KM; Choi SH; Chul-Kee P; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Yun TJ; Kim JH; Sohn CH
Eur Radiol; 2021 Dec; 31(12):9098-9109. PubMed ID: 34003350
[TBL] [Abstract][Full Text] [Related]
8. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
[TBL] [Abstract][Full Text] [Related]
9. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI.
Artzi M; Liberman G; Nadav G; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
J Neurooncol; 2016 May; 127(3):515-24. PubMed ID: 26754857
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
[TBL] [Abstract][Full Text] [Related]
12. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
[TBL] [Abstract][Full Text] [Related]
13. Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.
Larsson C; Groote I; Vardal J; Kleppestø M; Odland A; Brandal P; Due-Tønnessen P; Holme SS; Hope TR; Meling TR; Fosse E; Emblem KE; Bjørnerud A
Magn Reson Imaging; 2020 May; 68():106-112. PubMed ID: 32004711
[TBL] [Abstract][Full Text] [Related]
14. Adaptive neuro-fuzzy inference systems with k-fold cross-validation for energy expenditure predictions based on heart rate.
Kolus A; Imbeau D; Dubé PA; Dubeau D
Appl Ergon; 2015 Sep; 50():68-78. PubMed ID: 25959320
[TBL] [Abstract][Full Text] [Related]
15. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging-derived kep as a potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study.
Awasthi R; Pandey CM; Sahoo P; Behari S; Kumar V; Kumar S; Misra S; Husain N; Soni P; Rathore RK; Gupta RK
J Comput Assist Tomogr; 2012; 36(1):125-30. PubMed ID: 22261782
[TBL] [Abstract][Full Text] [Related]
17. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
[TBL] [Abstract][Full Text] [Related]
18. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
19. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
[TBL] [Abstract][Full Text] [Related]
20. Adaptive neuro-fuzzy inference system for classification of ECG signals using Lyapunov exponents.
Ubeyli ED
Comput Methods Programs Biomed; 2009 Mar; 93(3):313-21. PubMed ID: 19084286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
